MMWR. Morbidity and mortality weekly report最新文献_第4页

Notes from the Field: Emergency Department Use During the Los Angeles County Wildfires, January 2025.

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2025-02-06 DOI: 10.15585/mmwr.mm7403a2

Emily Kajita, Karen Chang, Vannalyn de Leon, Wesley Moss, Michael Lim, Sharon Balter, Annabelle de St Maurice

引用次数: 0

Notes from the Field: Serum Concentrations of Perfluoroalkyl and Polyfluoroalkyl Substances Among First Responders to the Maui Wildfires - Hawaii, September 2023.

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2025-02-06 DOI: 10.15585/mmwr.mm7403a1

Catherine C Beaucham, Rachel Zeiler, Kenneth Fent, Sophia K Chiu, Nicholas Somerville, Alexander Mayer, Jessica L Rinsky, Cheryl Estill

引用次数: 0

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2025. 免疫实践咨询委员会推荐的19岁或以上成人免疫计划-美国，2025年。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2025-01-16 DOI: 10.15585/mmwr.mm7402a3

A Patricia Wodi, Anindita N Issa, Charlotte A Moser, Sybil Cineas

引用次数: 0

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2025. 免疫实践咨询委员会推荐的18岁以下儿童和青少年免疫接种计划——美国，2025年。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2025-01-16 DOI: 10.15585/mmwr.mm7402a2

Anindita N Issa, A Patricia Wodi, Charlotte A Moser, Sybil Cineas

{"title":"Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2025.","authors":"Anindita N Issa, A Patricia Wodi, Charlotte A Moser, Sybil Cineas","doi":"10.15585/mmwr.mm7402a2","DOIUrl":"https://doi.org/10.15585/mmwr.mm7402a2","url":null,"abstract":"At its October 2024 meeting, the Advisory Committee on Immunization Practices* (ACIP) approved the Recommended Immunization Schedule for Child and Adolescent Ages 18 Years or Younger, United States, 2025. The schedule supports health care providers, as well as public health and other professionals, by providing a consolidated summary of current ACIP recommendations for vaccinating children and adolescents. The 2025 schedule includes several updates to the cover page, tables, notes, and appendix.† The addendum remains part of the schedule and will be used to summarize new or updated ACIP recommendations that occur before the next annual schedule update. Health care providers are strongly encouraged to use all parts of the schedule (the cover page, tables, notes, appendix, and addendum) together when making recommendations for individual patients. The 2025 child and adolescent immunization schedule can be found on the CDC website (https://www.cdc.gov/vaccines/hcp/imz-schedules/index.html).","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"74 2","pages":"26-29"},"PeriodicalIF":25.4,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737652/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143008309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Notes from the Field: Severe Health Outcomes Linked to Consumption of Mushroom-Based Psychoactive Microdosing Products - Arizona, June-October 2024. 来自现场的笔记：严重的健康结果与蘑菇为基础的精神活性微剂量产品的消费有关-亚利桑那州，2024年6月至10月。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2025-01-09 DOI: 10.15585/mmwr.mm7401a3

Heather L Walker, Maureen Roland, Steven Dudley, Kenneth Komatsu, Joli Weiss, Jamaica Dillard, Hsin-I Lin, Laura Rust, Traci Plummer, Rachel Berg, Stephen Everett, Arthur Chang, Michael Yeh, Johnni Daniel, Shane Brady

引用次数: 0

Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024. ≥50岁成人使用肺炎球菌结合疫苗的扩展建议：免疫实践咨询委员会的建议-美国，2024

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2025-01-09 DOI: 10.15585/mmwr.mm7401a1

Miwako Kobayashi, Andrew J Leidner, Ryan Gierke, Wei Xing, Emma Accorsi, Pedro Moro, Mini Kamboj, George A Kuchel, Robert Schechter, Jamie Loehr, Adam L Cohen

{"title":"Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.","authors":"Miwako Kobayashi, Andrew J Leidner, Ryan Gierke, Wei Xing, Emma Accorsi, Pedro Moro, Mini Kamboj, George A Kuchel, Robert Schechter, Jamie Loehr, Adam L Cohen","doi":"10.15585/mmwr.mm7401a1","DOIUrl":"10.15585/mmwr.mm7401a1","url":null,"abstract":"Before October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a pneumococcal conjugate vaccine (PCV) for all adults aged ≥65 years, as well as for those aged 19-64 years with risk conditions for pneumococcal disease who have not received a PCV or whose vaccination history is unknown. Options included either 20-valent PCV (PCV20; Prevnar20; Wyeth Pharmaceuticals) or 21-valent PCV (PCV21; CAPVAXIVE; Merck Sharp & Dohme) alone or 15-valent PCV (PCV15; VAXNEUVANCE; Merck Sharp & Dohme) in series with 23-valent pneumococcal polysaccharide vaccine (PPSV23; Pneumovax23; Merck Sharp & Dohme). There are additional recommendations for use of PCV20 or PCV21 for adults who started their pneumococcal vaccination series with 13-valent PCV (PCV13; Prevnar13; Wyeth Pharmaceuticals). The ACIP Pneumococcal Vaccines Work Group employed the Evidence to Recommendations framework to guide its deliberations on expanding the age-based PCV recommendation to include adults aged 50-64 years. On October 23, 2024, ACIP recommended a single dose of PCV for all PCV-naïve adults aged ≥50 years. Recommendations for PCVs among adults aged 19-49 years with risk conditions and PCV13-vaccinated adults have not changed from previous recommendations. This report summarizes evidence considered for these recommendations and provides updated clinical guidance for use of PCV.","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"74 1","pages":"1-8"},"PeriodicalIF":25.4,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11709131/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142951502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Occupational Exposure to Mercury at an Electronics Waste and Lamp Recycling Facility - Ohio, 2023. 电子废物和灯具回收设施的职业汞暴露-俄亥俄州，2023。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2025-01-09 DOI: 10.15585/mmwr.mm7401a2

Dallas S Shi, Melissa Charles, Catherine Beaucham, Sheldon Walker, Walter Alarcon, Scott E Brueck, Sophia K Chiu, Nicholas Somerville

{"title":"Occupational Exposure to Mercury at an Electronics Waste and Lamp Recycling Facility - Ohio, 2023.","authors":"Dallas S Shi, Melissa Charles, Catherine Beaucham, Sheldon Walker, Walter Alarcon, Scott E Brueck, Sophia K Chiu, Nicholas Somerville","doi":"10.15585/mmwr.mm7401a2","DOIUrl":"https://doi.org/10.15585/mmwr.mm7401a2","url":null,"abstract":"Workers in electronics waste and lamp recycling facilities are at risk of exposure to elemental mercury through inhalation of mercury vapor and mercury-containing dust. Employers at an electronics waste and lamp recycling facility in Ohio that crushes mercury-containing lamps expressed concerns about mercury exposure from work processes and requested a health hazard evaluation by CDC's National Institute for Occupational Safety and Health (NIOSH). In April 2023, NIOSH conducted a multidisciplinary investigation to assess elemental and inorganic mercury exposures, including epidemiologic, environmental, and ventilation assessments. Results indicated that mercury vapor was detected throughout the facility, with six of 14 workers having elevated urine mercury levels. These workers had a median job tenure of 8 months; four did not speak English, and five reported symptoms consistent with mercury toxicity, such as metallic or bitter taste, difficulty thinking, and changes in personality. Recommendations included improving the ventilation system, changing work practices to reduce mercury exposure, and providing training and communication tailored to the worker. As the electronic waste recycling industry continues to grow, it is important for employers to evaluate mercury exposure and safeguard employees using a hierarchy of controls. Health departments should consider monitoring occupational mercury exposure in recycling facilities, and clinicians should be aware of the potential for mercury toxicity among workers in these settings.","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"74 1","pages":"9-13"},"PeriodicalIF":25.4,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11709132/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142951504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

QuickStats: Health Center* Visit Rates,^† by Adults Aged ≥18 Years with Mental Health Disorder,^§ Substance Use Disorder, or Both, by Sex - United States, 2023. QuickStats：健康中心*访问率，†按年龄≥18岁患有精神健康障碍，§物质使用障碍或两者兼而有之的成年人，按性别分列-美国，2023。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2025-01-09 DOI: 10.15585/mmwr.mm7401a4

引用次数: 0

Tularemia - United States, 2011-2022. Tularemia -美国，2011-2022。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2025-01-02 DOI: 10.15585/mmwr.mm735152a1

Shannan N Rich, Alison F Hinckley, Austin Earley, Jeannine M Petersen, Paul S Mead, Kiersten J Kugeler

{"title":"Tularemia - United States, 2011-2022.","authors":"Shannan N Rich, Alison F Hinckley, Austin Earley, Jeannine M Petersen, Paul S Mead, Kiersten J Kugeler","doi":"10.15585/mmwr.mm735152a1","DOIUrl":"10.15585/mmwr.mm735152a1","url":null,"abstract":"Tularemia is a rare nationally notifiable zoonosis, caused by the tier-1 select agent Francisella tularensis, that has been reported from all U.S. states except Hawaii. Clinical manifestations typically include fever and localized symptoms that vary by route of infection. The case fatality rate of tularemia is typically <2% but can be higher depending on clinical manifestation and infecting strain. Tularemia is treatable with antibiotics. During 2011-2022, a total of 47 states reported 2,462 tularemia cases, but four central states (Arkansas, Kansas, Missouri, and Oklahoma) accounted for 50% of all reported cases. Incidence was highest among children aged 5-9 years (0.083 per 100,000 population) and adult males aged 65-84 years (range = 0.133-0.161). Incidence among American Indian or Alaska Native persons (0.260) was approximately five times that among White persons (0.057). The average annual incidence of tularemia in the United States during 2011-2022 (0.064) was 56% higher than that reported during 2001-2010 (0.041), largely resulting from increased reporting of probable cases. These findings might reflect an actual increase in human infection or improved case detection amid changes in commercially available laboratory tests during this period. Reducing tularemia incidence will require tailored prevention education; mitigating morbidity and mortality will require health care provider education, particularly among providers serving tribal populations, regarding early and accurate diagnosis and treatment.","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 5152","pages":"1152-1156"},"PeriodicalIF":25.4,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695070/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142907269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

QuickStats: Mental Health Treatment Trends* Among Adults Aged ≥18 Years, by Age Group - United States, 2019-2023^†. QuickStats: 2019-2023年美国年龄≥18岁成年人心理健康治疗趋势*

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-12-19 DOI: 10.15585/mmwr.mm7350a5

引用次数: 0